Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameSH Pioneer HLDG
Stock Code01345
Company Full NameTo be extracted
Industry醫療保健
Principal Activities主要於中國從事營銷及推廣進口醫藥產品及醫療器械,以及提供相關渠道管理服務。
Listing Date2013-11-05
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國上海市普陀區武威路88弄15號
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttp://www.pioneer-pharma.com
Share Registrar香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo data

Offering Information

Offering Mechanism To be extracted
Offer PriceHK$ 4.10 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer PeriodTo be extracted
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)To be confirmed
Stabilizing Manager (Greenshoe)—
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionTo be confirmed
Total Global Offering SizeHK$ 410,008,200

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway None
Avg Daily HK Mkt Cap ---
Est. Threshold ---
Analysis Result 无法确定入通路径

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss StatusTo be extracted
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day CloseHK$ 3.84
First Day OpenHK$ 3.9
First Day Change1.52%
First Day Volume113966000.0
First Day Turnover441414000.0
Use of Proceeds
1、約30%所得款項凈額或43180萬港幣,將用以繼續擴充我們的業務營運及提升我們的營銷、推廣及銷售能力; 2、約15%所得款項凈額或21590萬港幣,將用于升級現有及于湖北省建造新的物流及倉儲設施,以提升我們的倉儲能力及改善營運效率; 3、約5%所得款項凈額或7200萬港幣,將用于更換、改善及升級信息管理系統之硬件與軟件,以改善我們的管理及控制其推廣網絡及營運制造; 4、約25%所得款項凈額或35980萬港幣,將用于擴大產品組合; 5、約15%所得款項凈額或21590萬港幣,將用于海外供應商購入進口醫藥產品及醫療設備,以滿足不斷增長的需求; 6、約10%所得款項凈額或14390萬港幣,將用作我們的營運資金及其他一般企業用途。

Underwriting Syndicate

Sole Sponsor (1)
UBS Securities Hong Kong Limited CE BIN466
Overall Coordinators (1)
UBS Securities Hong Kong Limited CE BIN466
Joint Bookrunners (2)
UBS Securities Hong Kong Limited CE BIN466 星展亚洲融资有限公司 CE AAE430
Joint Lead Managers (2)
UBS Securities Hong Kong Limited CE BIN466 星展亚洲融资有限公司 CE AAE430

Cornerstone Investors

This stock has no cornerstone investors.

Directors & Management

PositionChinese nameEnglish Name
Chairman李新洲—
Company Secretary吳嘉雯—
No director data available.

Major Shareholders

Major Shareholders & Holdings李新洲及關連人士(67.16%)
About this page

This page shows SH Pioneer HLDG (01345) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect